Quick viewing(Text Mode)

Federal Register/Vol. 77, No. 20/Tuesday, January 31, 2012

Federal Register / Vol. 77, No. 20 / Tuesday, January 31, 2012 / Notices 4833

Drug Schedule DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE

2,5-Dimethoxy-4- I Drug Enforcement Administration Federal Bureau of Investigation ethylamphetamine (7399). 3,4-Methylenedioxyamphetamine I Manufacturer of Controlled [OMB Number 1110–0004] (7400). Substances; Notice of Registration 5-Methoxy-3,4- I Agency Information Collection methylenedioxyamphetamine By Notice dated June 7, 2011, and Activities; Proposed Collection, (7401). published in the Federal Register on Comments Requested: Extension of a N-Hydroxy-3,4- I June 16, 2011, 76 FR 35243, Archimica, Currently Approved Collection; methylenedioxyamphetamine (7402). Inc., 2460 W. Bennett Street, Number of Full-Time Law Enforcement 3,4-Methylenedioxy-N- I Springfield, Missouri 65807–1229, made Employees as of October 31 ethylamphetamine (7404). application by renewal to the Drug 3,4- I Enforcement Administration (DEA) to ACTION: 30-day Notice of Information Methylenedioxymethamphetam- be registered as a bulk manufacturer of Collection Under Review. ine (7405). the following basic classes of controlled 4-Methoxyamphetamine (7411) ... I substances: The Department of Justice, Federal 5-Methoxy-N-N- I Bureau of Investigation, Criminal Justice dimethyltryptamine (7431). Drug Schedule Information Services Division (CJIS) Alpha-methyltryptamine (7432) .... I will be submitting the following Diethyltryptamine (7434) ...... I Gamma Hydroxybutyric Acid I information collection request to the Dimethyltryptamine (7435) ...... I (2010). Office of Management and Budget 5-Methoxy-N,N- I (1100) ...... II (OMB) for review and clearance in diisopropyltryptamine (7439). (1205) ...... II Amphetamine (1100) ...... II accordance with established review (1724) ...... II procedures of the Paperwork Reduction (1105) ...... II Phenylacetone (8501) ...... II Lisdexamfetamine (1205) ...... II Methadone Intermediate (9254) ... II Act of 1995. The proposed information Tapentadol (9780) ...... II collection is published to obtain The company plans to manufacture comments from the public and affected small quantities of marihuana agencies. This proposed information The company plans to manufacture collection was previously published in derivatives for research purposes. In the listed controlled substances in bulk reference to drug code 7360 the Federal Register Volume 76, for distribution and sale to its customers Number 228, page 72977, on November (Marihuana), the company plans to bulk for Amphetamine (1100). manufacture cannabidiol. In reference to 28, 2011, allowing for a 60 day comment drug code 7370 The company plans to acquire the period. (Tetrahydrocannabinols), the company listed controlled substances in bulk The purpose of this notice is to allow will manufacture a synthetic THC. No from a domestic source in order to for an additional 30 days for public other activity for this drug code is manufacture other controlled substances comment until March 1, 2012. This authorized for this registration. in bulk for distribution to its customers. process is conducted in accordance with 5 CFR 1320.10. No comments or objections have been No comments or objections have been Written comments and/or suggestions received. DEA has considered the received. DEA has considered the regarding the items contained in this factors in 21 U.S.C. 823(a) and factors in 21 U.S.C. 823(a) and notice, especially the estimated public determined that the registration of determined that the registration of burden and associated response time, Cayman Chemical Company to Archimica, Inc., to manufacture the should be directed to Mr. Gregory E. manufacture the listed basic classed of listed basic classes of controlled Scarbro, Unit Chief, Federal Bureau of controlled substances is consistent with substances is consistent with the public Investigation, CJIS Division, Module E– the public interest at this time. DEA has interest at this time. DEA has 3, 1000 Custer Hollow Road, Clarksburg, investigated Cayman Chemical investigated Archimica, Inc., to ensure West Virginia 26306; facsimile (304) Company to ensure that the company’s that the company’s registration is 625–3566. registration is consistent with the public consistent with the public interest. The Written comments and suggestions interest. The investigation has included investigation has included inspection from the public and affected agencies inspection and testing of the company’s and testing of the company’s physical concerning the proposed collection of physical security systems, verification security systems, verification of the information are encouraged. Comments of the company’s compliance with state company’s compliance with state and should address one or more of the and local laws, and a review of the local laws, and a review of the following four points: company’s background and history. company’s background and history. (1) Evaluate whether the proposed Therefore, pursuant to 21 U.S.C. 823(a), Therefore, pursuant to 21 U.S.C. collection of information is necessary and in accordance with 21 CFR 1301.33, 823(a), and in accordance with 21 CFR for the proper performance of the the above named company is granted 1301.33, the above named company is functions of the agency, including registration as a bulk manufacturer of granted registration as a bulk whether the information will have the basic classes of controlled manufacturer of the basic classes of practical utility; substances listed. controlled substances listed. (2) Evaluate the accuracy of the Dated: January 23, 2012. Dated: January 23, 2012. agency’s estimate of the burden of the Joseph T. Rannazzisi, Joseph T. Rannazzisi, proposed collection of information, Deputy Assistant Administrator, Office of Deputy Assistant Administrator, Office of including the validity of the Diversion Control, Drug Enforcement Diversion Control, Drug Enforcement methodology and assumptions used; Administration. Administration. (3) Enhance the quality, utility, and [FR Doc. 2012–1977 Filed 1–30–12; 8:45 am] [FR Doc. 2012–1981 Filed 1–30–12; 8:45 am] clarity of the information to be BILLING CODE 4410–09–P BILLING CODE 4410–09–P collected; and

VerDate Mar<15>2010 15:20 Jan 30, 2012 Jkt 226001 PO 00000 Frm 00077 Fmt 4703 Sfmt 4703 E:\FR\FM\31JAN1.SGM 31JAN1 wreier-aviles on DSK5TPTVN1PROD with NOTICES